The Baupost Group, the hedge fund firm run by famed investor Seth Klarman (Trades, Portfolio), just reported their first quarter portfolio. Seth Klarman (Trades, Portfolio) buys Cheniere Energy Inc, Keryx Biopharmaceuticals Inc, Idenix Pharmaceuticals Inc, PBF Energy Inc, RF Micro Devices Inc, Triquint Semiconductor, Viasat Inc, Theravance Inc, Keryx Biopharmaceuticals Inc, sells BP PLC, Fidelity National Financial Inc, Rovi Corp, Enzon Pharmaceuticals Inc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, The Baupost Group. As of 03/31/2014, The Baupost Group owns 20 stocks with a total value of $4.1 billion. These are the details of the buys and sells.
- New Purchases: LNG, KERX, RFMD, TQNT, KERX,
- Added Positions: IDIX, PBF, VSAT, THRX,
- Reduced Positions: BP,
- Sold Out: FNF, ROVI, ENZN,
For the details of Seth Klarman (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Seth+Klarman
This is the sector weightings of his portfolio:
| Technology | 52.8% |
| Healthcare | 26.7% |
| Energy | 11.4% |
| Basic Materials | 2.1% |
| Consumer Defensive | 0.4% |
These are the top 5 holdings of Seth Klarman (Trades, Portfolio)
1. Micron Technology Inc (MU) - 51,655,434 shares, 29.5% of the total portfolio.
2. Viasat Inc (VSAT) - 11,395,900 shares, 19.0% of the total portfolio. Shares added by 2.4%
3. Theravance Inc (THRX) - 20,705,801 shares, 15.5% of the total portfolio. Shares added by 2.79%
4. Cheniere Energy Inc (LNG) - 5,660,000 shares, 7.6% of the total portfolio. New Position
5. Idenix Pharmaceuticals Inc (IDIX) - 53,331,109 shares, 7.3% of the total portfolio. Shares added by 44.49%
New Purchase: Cheniere Energy Inc (LNG, Financial)
Seth Klarman (Trades, Portfolio) initiated holdings in Cheniere Energy Inc. His purchase prices were between $40.88 and $54.87, with an estimated average price of $47.65. The impact to his portfolio due to this purchase was 7.6%. His holdings were 5,660,000 shares as of 03/31/2014. Cheniere Energy Inc, a Delaware corporation, is a Houston-based energy company primarily engaged in LNG-related businesses. Cheniere Energy Inc has a market cap of $13.56 billion; its shares were traded at around $56.98 with and P/S ratio of 46.80.
New Purchase: Keryx Biopharmaceuticals Inc (KERX, Financial)
Seth Klarman (Trades, Portfolio) initiated holdings in Keryx Biopharmaceuticals Inc. His purchase prices were between $12.16 and $16.88, with an estimated average price of $14.98. The impact to his portfolio due to this purchase was 2.6%. His holdings were 6,310,850 shares as of 03/31/2014. Keryx Biopharmaceuticals, Inc is a Delaware corporation incorporated in Delaware in October 1998. Keryx Biopharmaceuticals Inc has a market cap of $1.17 billion; its shares were traded at around $12.79 with and P/S ratio of 107.10.
New Purchase: RF Micro Devices Inc (RFMD, Financial)
Seth Klarman (Trades, Portfolio) initiated holdings in RF Micro Devices Inc. His purchase prices were between $4.51 and $7.93, with an estimated average price of $6.09. The impact to his portfolio due to this purchase was 1.3%. His holdings were 6,585,000 shares as of 03/31/2014. RF Micro Devices, Inc. was incorporated under the laws of the State of North Carolina in 1991. Rf Micro Devices Inc has a market cap of $2.46 billion; its shares were traded at around $8.72 with and P/S ratio of 2.10.
New Purchase: Triquint Semiconductor (TQNT, Financial)
Seth Klarman (Trades, Portfolio) initiated holdings in Triquint Semiconductor. His purchase prices were between $8.07 and $13.55, with an estimated average price of $10.28. The impact to his portfolio due to this purchase was 1.2%. His holdings were 3,825,000 shares as of 03/31/2014. Triquint Semiconductor was incorporated in California in 1981 and reincorporated in Delaware on February 12, 1997. Triquint Semiconductor has a market cap of $2.49 billion; its shares were traded at around $14.51 with and P/S ratio of 2.60. Triquint Semiconductor had an annual average earnings growth of 11.00% over the past 10 years.
New Purchase: Keryx Biopharmaceuticals Inc (KERX, Financial)
Seth Klarman (Trades, Portfolio) initiated holdings in Keryx Biopharmaceuticals Inc. The impact to his portfolio due to this purchase was 3.11%. His holdings were 9,151,600 shares as of 03/31/2014. Keryx Biopharmaceuticals, Inc is a Delaware corporation incorporated in Delaware in October 1998. Keryx Biopharmaceuticals Inc has a market cap of $1.17 billion; its shares were traded at around $12.79 with and P/S ratio of 107.10.
Sold Out: Fidelity National Financial Inc (FNF, Financial)
Seth Klarman (Trades, Portfolio) sold out his holdings in Fidelity National Financial Inc. His sale prices were between $29.78 and $33.22, with an estimated average price of $31.66. Fidelity National Financial, Inc. was incorporated in the State of Delaware. Fidelity National Financial Inc has a market cap of $9.32 billion; its shares were traded at around $33.66 with a P/E ratio of 19.30 and P/S ratio of 1.00. The dividend yield of Fidelity National Financial Inc stocks is 2.00%. Fidelity National Financial Inc had an annual average earnings growth of 17.60% over the past 5 years.
Sold Out: Rovi Corp (ROVI, Financial)
Seth Klarman (Trades, Portfolio) sold out his holdings in Rovi Corp. His sale prices were between $19.38 and $25.2, with an estimated average price of $22.8. Rovi Corp, a Delaware corporation was formed in 2007. Rovi Corp has a market cap of $2.18 billion; its shares were traded at around $23.00 with and P/S ratio of 4.20. Rovi Corp had an annual average earnings growth of 5.80% over the past 10 years. GuruFocus rated Rovi Corp the business predictability rank of 3.5-star.
Sold Out: Enzon Pharmaceuticals Inc (ENZN)
Seth Klarman (Trades, Portfolio) sold out his holdings in Enzon Pharmaceuticals Inc. His sale prices were between $0.861 and $1.26, with an estimated average price of $1.04. Enzon Pharmaceuticals, Inc., a biotechnology company, was founded on 1981. Enzon Pharmaceuticals Inc has a market cap of $40.100 million; its shares were traded at around $0.91 with a P/E ratio of 2.30 and P/S ratio of 1.40.
Added: Idenix Pharmaceuticals Inc (IDIX, Financial)
Seth Klarman (Trades, Portfolio) added to his holdings in Idenix Pharmaceuticals Inc by 44.49%. His purchase prices were between $5.82 and $8.04, with an estimated average price of $6.96. The impact to his portfolio due to this purchase was 2.25%. His holdings were 53,331,109 shares as of 03/31/2014. Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. Idenix Pharmaceuticals Inc has a market cap of $859.800 million; its shares were traded at around $5.70 .
Added: PBF Energy Inc (PBF, Financial)
Seth Klarman (Trades, Portfolio) added to his holdings in PBF Energy Inc by 174.04%. His purchase prices were between $23.79 and $31.46, with an estimated average price of $26.73. The impact to his portfolio due to this purchase was 2.16%. His holdings were 5,416,606 shares as of 03/31/2014. PBF Energy Inc is a Delaware corporation incorporated on November 7, 2011. Pbf Energy Inc has a market cap of $2.91 billion; its shares were traded at around $30.06 with a P/E ratio of 22.10 and P/S ratio of 0.10. The dividend yield of Pbf Energy Inc stocks is 4.00%.
Added: Viasat Inc (VSAT, Financial)
Seth Klarman (Trades, Portfolio) added to his holdings in Viasat Inc by 2.4%. His purchase prices were between $56.04 and $73.62, with an estimated average price of $64.86. The impact to his portfolio due to this purchase was 0.45%. His holdings were 11,395,900 shares as of 03/31/2014. Viasat Inc was incorporated in California in 1986, and subsequently reincorporated in Delaware in 1996. Viasat Inc has a market cap of $2.72 billion; its shares were traded at around $58.99 with and P/S ratio of 2.00. Viasat Inc had an annual average earnings growth of 9.20% over the past 10 years.
Added: Theravance Inc (THRX, Financial)
Seth Klarman (Trades, Portfolio) added to his holdings in Theravance Inc by 2.79%. His purchase prices were between $30.17 and $40.49, with an estimated average price of $36.39. The impact to his portfolio due to this purchase was 0.42%. His holdings were 20,705,801 shares as of 03/31/2014. Theravance Inc., was incorporated in Delaware in November 1996 under the name Advanced Medicine, Inc, and began operations in May 1997. Theravance Inc has a market cap of $3.2 billion; its shares were traded at around $28.37 with and P/S ratio of 819.10.
Reduced: BP PLC (BP, Financial)
Seth Klarman (Trades, Portfolio) reduced to his holdings in BP PLC by 44.12%. His sale prices were between $46.04 and $50.67, with an estimated average price of $48.22. The impact to his portfolio due to this sale was -3.44%. Seth Klarman (Trades, Portfolio) still held 3,166,413 shares as of 03/31/2014. BP PLC operates as an integrated oil and gas company and is the parent company of the BP group of companies. Bp Plc has a market cap of $173.49 billion; its shares were traded at around $50.96 with a P/E ratio of 15.80 and P/S ratio of 0.40. The dividend yield of Bp Plc stocks is 4.50%. Bp Plc had an annual average earnings growth of 20.60% over the past 5 years.
